Pharmacology, Toxicology and Pharmaceutical Science
Klebsiella pneumoniae
96%
Cefiderocol
86%
Cephalosporin
86%
Microbiome
86%
Siderophore
57%
Penicillinase
50%
Infectious Agent
45%
Antiinfective Agent
43%
Periodontitis
43%
Antimicrobial Resistance
38%
Microflora
37%
Dysbiosis
33%
Periodontal Disease
33%
Antibiotics
31%
Polymyxin B Nonapeptide
31%
Carbapenemase
31%
Escherichia coli
28%
Phenylalanine
28%
Extended Spectrum Beta Lactamase
28%
Antibiotic Resistance
28%
Antibacterial Activity
28%
Neoplasm
28%
Tumor Growth
28%
Effusion
28%
2,5-Dimethoxy-4-iodoamphetamine
28%
Obesity
28%
Sepsis
28%
Anti-Inflammatory Drug
28%
Intestine Flora
28%
Vacuolating Toxin
28%
Arginine
28%
microRNA 155
28%
Dental Caries
28%
Potassium Iodide
28%
Hydrocortisone
28%
Azithromycin
28%
Candida Auris
28%
Microorganism
19%
RNA 16S
16%
Epileptic Absence
14%
Cytokine
13%
Mouse
10%
Immunogenicity
10%
Methicillin-Resistant Staphylococcus Aureus
9%
Cytotoxicity
9%
Enterococcus faecium
9%
Vancomycin-Resistant Enterococcus
9%
Tumor Necrosis Factor
9%
Pathogenesis
9%
Macrolide
8%
Keyphrases
Outer Membrane Permeabilization
57%
Tobacco Varieties
57%
Cefiderocol
57%
Subgingival Microbiota
57%
Periodontal Health
57%
Supragingival
28%
Antibacterial Activity
28%
Naphthylamide
28%
Aza-Michael Addition Reaction
28%
Rapid Access
28%
Multiplex Real-time Polymerase Chain Reaction
28%
Ytterbium Trifluoride
28%
Pseudomonas Aeruginosa (P. aeruginosa)
28%
ParC Gene
28%
GyrA mutation
28%
Thiazolo
28%
Cleaning Solution
28%
Chemical Disinfectants
28%
Horizontal Axis
28%
Diastereoselective
28%
Resistance-modifying Agents
28%
International Journals
28%
Cuminaldehyde
28%
Iron Acquisition Systems
28%
Siderophore Cephalosporin
28%
Antibiotic Resistance Determinants
28%
Antibiotic Resistance Plasmids
28%
Fatal Pneumonia
28%
Extreme Resistance
28%
Biofilm Growth
28%
Infected Root Canal
28%
Intraoral Appliance
28%
Bacterial Levels
28%
Benzopyrane
28%
Persisters
28%
Synergistic Activity
28%
Non-ulcerogenic
28%
Gastric Diseases
28%
Vacuolating Cytotoxin
28%
Salivary microRNA
28%
MicroRNA-155 (miR-155)
28%
Benzoxazepine
28%
Imidazopyrazine
28%
Modular Strategy
28%
Non-invasive Biomarkers
28%
Salivary Microbiome
28%
Infectious Diseases
28%
Silver Diamine Fluoride
28%
Plaque Biofilm
28%
Female Healthcare Workers
28%
Immunology and Microbiology
Klebsiella pneumoniae
100%
Antimicrobial Resistance
86%
Subgingival Microbiome
86%
Infectious Agent
68%
Microbiome
62%
Periodontitis
50%
Oral Microbiome
47%
Gut Microbiome
43%
Microflora
43%
Microorganism
33%
Plasmid
32%
Escherichia coli
28%
Antimicrobial Activity
28%
Tumor Immunogenicity
28%
Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae
28%
Antibacterial Activity
28%
Plant Extract
28%
Helicobacter Pylori
28%
Real Time Polymerase Chain Reaction
28%
Clustered Regularly Interspaced Short Palindromic Repeat
28%
Michael Addition
28%
Inflammatory Bowel Disease
28%
Potassium Iodide
28%
Antiinflammatory Activity
28%
Outer Membrane
28%
Biofilm
21%
Teeth
21%
Homeostasis
20%
Body Weight
17%
Replicon
16%
Tannerella forsythia
15%
Human Cell
14%
Immune System
14%
Bacterial Cell
14%
Cytotoxicity
14%
Methicillin-Resistant Staphylococcus Aureus
14%
Minimum Inhibitory Concentration
14%
Vancomycin-Resistant Enterococcus
14%
Enterococcus faecium
14%
Microbial Pathogenesis
14%
Mediator
14%
Cell Line
14%
Proinflammatory Cytokine
14%
Tumor Necrosis Factor
14%
Interleukin-1
14%
Human Pathogen
14%
Interleukin-6
14%
Immunomodulation
9%
Bacterial Gene
9%
Veillonella
9%